External reports (aggregated public sources), Value Investors Club

Value Investors Club

External reports (aggregated public sources)

Equity Bottom-Up

<ul><li>AVITA Medical has a 75% market share in the burns market, surpassing competitors</li><li>The company's recent financial performance has been strong, with an 84% increase in revenue in 2020</li><li>AVITA Medical has significant potential for growth and value creation in the future, given its position in the burns industry and growing market opportunity</li></ul><p><em>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.</em></p>

AVITA Medical has a 75% market share in the burns market, surpassing competitorsThe company's recent financial performance has been strong, with an 84% increase in revenue in 2020AVITA Medical has significant potential for growth and value creation in the future, given its position in the burns industry and growing market opportunityThis content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Avita Medical Inc (RCEL) - Monday, Apr 15, 2024

United States

AVITA Medical, Inc. operates as a medicine company. The Company focuses on the development and commercialization of therapies to address unmet medical needs in patients with burns, chronic wounds, and aesthetics indications. AVITA Medical serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Avita Medical (RCEL US)

Avita Medical Inc (RCEL) - Monday, Apr 15, 2024

AVITA Medical has significant potential for growth and value creation in the future, given its position in the burns industry and growing market...

Value Investors Club

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)